HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenichi Ishizawa Selected Research

ranimustine

12/2020Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
11/2018Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma.
11/2012Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenichi Ishizawa Research Topics

Disease

19Lymphoma (Lymphomas)
12/2020 - 07/2004
16Neoplasms (Cancer)
05/2020 - 01/2007
11Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 05/2007
10Hypertension (High Blood Pressure)
10/2020 - 06/2012
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2020 - 05/2007
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2022 - 12/2006
8Multiple Myeloma
10/2022 - 05/2007
8Anemia
01/2016 - 01/2007
7Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 07/2004
7Disease Progression
05/2020 - 01/2009
6Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2021 - 01/2009
5Proteinuria
11/2022 - 11/2010
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2005
5Thrombocytopenia (Thrombopenia)
01/2022 - 11/2010
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 09/2010
5Leukemia
05/2017 - 09/2004
5T-Cell Lymphoma (Lymphoma, T Cell)
11/2014 - 10/2006
4Exanthema (Rash)
06/2022 - 09/2004
4Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 09/2004
4Pneumonia (Pneumonitis)
08/2021 - 04/2004
4Chronic Renal Insufficiency
10/2020 - 03/2017
4Hodgkin Disease (Hodgkin's Disease)
10/2019 - 10/2006
4Philadelphia Chromosome
01/2015 - 09/2004
3Hemorrhage
09/2022 - 07/2009
3Neutropenia
02/2021 - 01/2016
3Diarrhea
07/2020 - 01/2012
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2019 - 10/2006
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 01/2007
3Infections
01/2017 - 04/2004
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2011 - 01/2007
2Cardiotoxicity
09/2022 - 11/2012
2Febrile Neutropenia
01/2022 - 08/2021
2Hyperaldosteronism (Conn Syndrome)
12/2021 - 01/2017
2Lymphopenia (Lymphocytopenia)
02/2021 - 04/2017
2Hemophilia A (Haemophilia)
01/2021 - 07/2009
2Chromosome Aberrations (Chromosome Abnormalities)
12/2020 - 05/2020
2Kidney Diseases (Kidney Disease)
10/2020 - 08/2014
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2020 - 04/2020
2Blast Crisis (Blast Phase)
07/2020 - 05/2020
2Hyperuricemia
12/2019 - 02/2014
2Nausea
07/2019 - 04/2017
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2014
2Thrombotic Microangiopathies
01/2019 - 01/2012
2Hyperkalemia
01/2019 - 11/2016
2Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 03/2014
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
11/2017 - 04/2014

Drug/Important Bio-Agent (IBA)

14Rituximab (Mabthera)FDA Link
05/2022 - 05/2007
7Bendamustine HydrochlorideFDA Link
05/2022 - 09/2010
7Imatinib Mesylate (Gleevec)FDA Link
05/2020 - 09/2004
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 04/2004
6SaltsIBA
10/2020 - 06/2012
4Dexamethasone (Maxidex)FDA LinkGeneric
10/2022 - 05/2016
4Pharmaceutical PreparationsIBA
09/2022 - 11/2010
4AldosteroneIBA
12/2021 - 01/2014
4Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2012
4Etoposide (VP 16)FDA LinkGeneric
12/2020 - 11/2009
4Lenalidomide (CC 5013)FDA Link
04/2017 - 05/2016
4Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
03/2017 - 02/2012
4Thalidomide (Thalomid)FDA Link
05/2016 - 05/2007
3Cytotoxins (Cytolysins)IBA
09/2022 - 09/2010
3bosutinibIBA
06/2022 - 01/2015
3Cytarabine (Cytosar-U)FDA LinkGeneric
08/2021 - 07/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2013
3ranimustineIBA
12/2020 - 11/2012
3Dasatinib (BMS 354825)FDA Link
05/2020 - 06/2011
3CreatinineIBA
01/2020 - 11/2010
3Hormones (Hormone)IBA
04/2019 - 04/2013
3CytokinesIBA
01/2016 - 01/2013
3Proteins (Proteins, Gene)FDA Link
01/2011 - 10/2003
2Uric Acid (Urate)IBA
11/2022 - 12/2019
2isatuximabIBA
10/2022 - 12/2020
2venetoclaxIBA
01/2022 - 08/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2014
2Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2020
2Factor VIIa (Activated Factor VII)IBA
01/2021 - 07/2009
2Carboplatin (JM8)FDA LinkGeneric
12/2020 - 11/2012
2Phosphates (Orthophosphate)IBA
10/2020 - 11/2019
2Estrogen ReceptorsIBA
08/2020 - 04/2019
2Tyrosine Kinase InhibitorsIBA
05/2020 - 11/2012
2Immunosuppressive Agents (Immunosuppressants)IBA
04/2020 - 01/2019
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2020 - 01/2020
2Cystatin CIBA
01/2020 - 01/2018
2Brentuximab VedotinIBA
10/2019 - 07/2014
2Monoclonal AntibodiesIBA
04/2019 - 01/2017
2Tacrolimus (Prograf)FDA LinkGeneric
01/2019 - 04/2007
2aliskirenFDA Link
01/2019 - 08/2014
2Phosphotransferases (Kinase)IBA
01/2019 - 08/2005
2Antihypertensive Agents (Antihypertensives)IBA
01/2019 - 08/2014
2Dacarbazine (DIC)FDA LinkGeneric
05/2017 - 01/2013

Therapy/Procedure

22Drug Therapy (Chemotherapy)
01/2022 - 05/2007
22Therapeutics
07/2021 - 01/2007
9Hematopoietic Stem Cell Transplantation
12/2020 - 09/2004
6Stem Cell Transplantation
07/2021 - 04/2004
3Chemoradiotherapy
11/2014 - 11/2009
3Aftercare (After-Treatment)
11/2012 - 07/2004
3Transplantation
07/2011 - 04/2004
2Cell Transplantation
09/2022 - 01/2022
2Plasma Exchange
01/2021 - 06/2019
2Immunotherapy
06/2019 - 05/2010
2Salvage Therapy
11/2018 - 11/2012